U.S. markets close in 2 hours 40 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W
16.42+0.70 (+4.42%)
As of 1:20PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close15.72
Open15.74
Bid16.47 x 1800
Ask16.63 x 1000
Day's Range15.65 - 16.70
52 Week Range13.11 - 18.90
Volume110,067
Avg. Volume563,855
Market Cap3.986B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-15.71
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Goldman Sachs: These 3 Stocks Could Spike Over 60%
    TipRanks

    Goldman Sachs: These 3 Stocks Could Spike Over 60%

    Just when we thought that COVID was starting to fade, the Delta variant has come our way. Is this the dreaded vaccine-resistant wave that will put economies back into lockdown? So far, at least, that doesn’t appear so – while this variant has shown the ability to infect people who are fully vaccinated, the vaccines have also shown efficacy in preventing serious illness, even from the Delta variant. What we’re looking at is an increase in cases, but a decrease in serious hospitalizations. Taking

  • IPO market sets post-2000 record in Q2: Renaissance Capital
    Yahoo Finance

    IPO market sets post-2000 record in Q2: Renaissance Capital

    The IPO market set another record amid a landmark quarter for Q2 2021, according to a report published by Renaissance Capital — 113 IPOs raised $39.9 billion in Q2, marking the “busiest quarter for IPOs in over two decades."

  • 3 Biotechs and a Real Estate Finance Company Went Public Today. Only One Gained.
    Barrons.com

    3 Biotechs and a Real Estate Finance Company Went Public Today. Only One Gained.

    The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen, and Angel Oak Mortgage. Shares of Verve rocketed 68%.